Wednesday, January 13, 2021 2:40:32 PM
Since it's been established that 3rd parties to CytoDyn are fodder for posting on this board and being subject to scrutiny.
Has anybody wondered about where those SEC FOIA requests come from that keep getting posted here in all their glory?
[SPOILER: I've known this for a while...I just wanted to wait for just the right time to reveal it.]
Well, it seems that the SEC keeps a log of those requests and publishes them on their web site here for the public to access:
https://www.sec.gov/foia/docs/foia-logs.htm
There's one recent log entry that brings some interesting things to light:
https://www.sec.gov/files/data/foia-logs/foia-log-november-2020-b7a-exemption.csv
So, there seems to be someone by the name of "Brian Z. Barr" who is very interested in CytoDyn and the SEC. In fact, there have been entries in SEC's FOIA Logs for several months in succession requesting the same information from the same individual.
Hmmmmm....just who is "Brian Z. Barr" ? Well, I know a lot now....
....more to come.....
Has anybody wondered about where those SEC FOIA requests come from that keep getting posted here in all their glory?
[SPOILER: I've known this for a while...I just wanted to wait for just the right time to reveal it.]
Well, it seems that the SEC keeps a log of those requests and publishes them on their web site here for the public to access:
https://www.sec.gov/foia/docs/foia-logs.htm
There's one recent log entry that brings some interesting things to light:
https://www.sec.gov/files/data/foia-logs/foia-log-november-2020-b7a-exemption.csv
So, there seems to be someone by the name of "Brian Z. Barr" who is very interested in CytoDyn and the SEC. In fact, there have been entries in SEC's FOIA Logs for several months in succession requesting the same information from the same individual.
Hmmmmm....just who is "Brian Z. Barr" ? Well, I know a lot now....
....more to come.....
Recent CYDY News
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 05/21/2026 04:15:12 AM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 05/20/2026 09:08:39 PM
- CytoDyn to Present at the LD Micro Invitational XVI • GlobeNewswire Inc. • 05/15/2026 12:30:00 PM
- CNS Drug Delivery Breakthroughs Unlock Significant Biotech Market Opportunities • InvestorsHub NewsWire • 05/11/2026 01:00:00 PM
- CNS Drug Delivery Breakthroughs Unlock Significant Biotech Market Opportunities • GlobeNewswire Inc. • 05/11/2026 12:30:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 04/30/2026 08:32:50 PM
- CytoDyn Announces First Patient Dosed in Expanded Access Program for Leronlimab in Triple-Negative Breast Cancer • GlobeNewswire Inc. • 04/27/2026 12:30:00 PM
- CytoDyn to Host Investor Webcast • GlobeNewswire Inc. • 04/23/2026 12:30:00 PM
- Form S-1 - General form for registration of securities under the Securities Act of 1933 • Edgar (US Regulatory) • 04/22/2026 09:21:50 PM
- CytoDyn Presents New Leronlimab Data in Metastatic Colorectal Cancer at AACR Annual Meeting 2026 • GlobeNewswire Inc. • 04/22/2026 12:30:00 PM
- CytoDyn Completes Enrollment in Phase 2 Metastatic Colorectal Cancer Study • GlobeNewswire Inc. • 04/21/2026 08:10:00 PM
- CytoDyn Presents New Leronlimab Data in Metastatic Triple-Negative Breast Cancer at AACR Annual Meeting 2026 • GlobeNewswire Inc. • 04/20/2026 12:30:00 PM
- CytoDyn to Present at the AACR Annual Meeting 2026 • GlobeNewswire Inc. • 04/14/2026 12:30:00 PM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 04/08/2026 09:15:18 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 04/08/2026 12:30:28 PM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 03/25/2026 09:16:10 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/24/2026 09:24:23 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/24/2026 09:23:14 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/24/2026 09:22:42 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/24/2026 09:21:33 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/24/2026 09:20:57 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/24/2026 09:20:20 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/24/2026 09:15:24 PM
- CytoDyn Presents at AACR Special Conference in Cancer Research: Brain Cancer • GlobeNewswire Inc. • 03/24/2026 12:30:00 PM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 03/09/2026 09:15:18 PM
